Jane Street Group LLC Has $1.73 Million Holdings in Takeda Pharmaceutical Company Limited (NYSE:TAK)

Jane Street Group LLC trimmed its stake in Takeda Pharmaceutical Company Limited (NYSE:TAK) by 91.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,830 shares of the company’s stock after selling 1,340,466 shares during the period. Jane Street Group LLC’s holdings in Takeda Pharmaceutical were worth $1,732,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in TAK. Catalytic Wealth RIA LLC grew its position in Takeda Pharmaceutical by 4.0% during the second quarter. Catalytic Wealth RIA LLC now owns 21,703 shares of the company’s stock worth $281,000 after buying an additional 841 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in shares of Takeda Pharmaceutical by 38.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,082 shares of the company’s stock worth $43,000 after acquiring an additional 859 shares during the period. Hexagon Capital Partners LLC increased its position in shares of Takeda Pharmaceutical by 34.3% during the third quarter. Hexagon Capital Partners LLC now owns 4,419 shares of the company’s stock valued at $63,000 after purchasing an additional 1,129 shares during the period. Gallacher Capital Management LLC raised its stake in shares of Takeda Pharmaceutical by 7.0% in the second quarter. Gallacher Capital Management LLC now owns 17,365 shares of the company’s stock valued at $225,000 after purchasing an additional 1,136 shares in the last quarter. Finally, Cutter & CO Brokerage Inc. lifted its position in Takeda Pharmaceutical by 3.3% in the second quarter. Cutter & CO Brokerage Inc. now owns 41,974 shares of the company’s stock worth $543,000 after purchasing an additional 1,347 shares during the period. Institutional investors own 9.17% of the company’s stock.

Takeda Pharmaceutical Stock Performance

Shares of Takeda Pharmaceutical stock opened at $13.17 on Thursday. The company’s fifty day moving average price is $13.65 and its two-hundred day moving average price is $13.88. The firm has a market capitalization of $41.91 billion, a PE ratio of 22.71, a price-to-earnings-growth ratio of 0.25 and a beta of 0.51. Takeda Pharmaceutical Company Limited has a 52-week low of $12.57 and a 52-week high of $15.08. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.28 and a quick ratio of 0.77.

Takeda Pharmaceutical Company Profile

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience.